Feder Julie B — SEC insider filings
SEC reporting owner CIK 1710237. 9 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2021-10-29 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 41,040 shares, $448,117 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 25,131 shares @ $12.03 ($302,361) in Aura Biosciences, Inc., filed 2024-10-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aura Biosciences, Inc. (AURA) | Chief Financial Officer | 8 | — | 5 legs · 41,040 sh · $448,117 | 14 |
| Obsidian Therapeutics, Inc. (OBX) | Chief Financial Officer | 1 | — | — | 1 |
Insider filings — Feder Julie B
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Obsidian Therapeutics, Inc. (OBX) | Grant/award (A): 164,790 (derivative) @ $0 | EDGAR |
| 2024-10-21 | 4 | Aura Biosciences, Inc. (AURA) | Option exercise (M): 17,500 @ $2.74 · Option exercise (M): 2,631 @ $4.25 · Option exercise (M): 5,000 @ $5.48 · Sale (S): 25,131 @ $12.03 · Option exercise (M): 17,500 (derivative) @ $0 · Option exercise (M): 2,631 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-02 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 71,285 @ $0 · Grant/award (A): 103,715 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 6,609 @ $7.64 | EDGAR |
| 2023-11-07 | 4 | Aura Biosciences, Inc. (AURA) | Option exercise (M): 3,900 @ $2.74 · Sale (S): 3,900 @ $12.07 · Option exercise (M): 3,900 (derivative) @ $0 | EDGAR |
| 2023-11-01 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 3,385 @ $6.82 | EDGAR |
| 2023-01-23 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 48,750 @ $0 · Grant/award (A): 75,000 (derivative) | EDGAR |
| 2022-11-02 | 4 | Aura Biosciences, Inc. (AURA) | Sale (S): 2,015 @ $12.45 | EDGAR |
| 2021-10-29 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 26,250 @ $0 · Grant/award (A): 112,500 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1710237 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs